1. Home
  2. RCEL vs LCNB Comparison

RCEL vs LCNB Comparison

Compare RCEL & LCNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • LCNB
  • Stock Information
  • Founded
  • RCEL N/A
  • LCNB 1877
  • Country
  • RCEL United States
  • LCNB United States
  • Employees
  • RCEL N/A
  • LCNB N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • LCNB Major Banks
  • Sector
  • RCEL Health Care
  • LCNB Finance
  • Exchange
  • RCEL Nasdaq
  • LCNB Nasdaq
  • Market Cap
  • RCEL 227.5M
  • LCNB 216.4M
  • IPO Year
  • RCEL N/A
  • LCNB N/A
  • Fundamental
  • Price
  • RCEL $9.21
  • LCNB $14.17
  • Analyst Decision
  • RCEL Strong Buy
  • LCNB
  • Analyst Count
  • RCEL 4
  • LCNB 0
  • Target Price
  • RCEL $17.25
  • LCNB N/A
  • AVG Volume (30 Days)
  • RCEL 201.7K
  • LCNB 26.6K
  • Earning Date
  • RCEL 05-08-2025
  • LCNB 04-29-2025
  • Dividend Yield
  • RCEL N/A
  • LCNB 6.23%
  • EPS Growth
  • RCEL N/A
  • LCNB N/A
  • EPS
  • RCEL N/A
  • LCNB 0.97
  • Revenue
  • RCEL $64,251,000.00
  • LCNB $79,237,000.00
  • Revenue This Year
  • RCEL $62.33
  • LCNB N/A
  • Revenue Next Year
  • RCEL $30.59
  • LCNB $7.44
  • P/E Ratio
  • RCEL N/A
  • LCNB $14.61
  • Revenue Growth
  • RCEL 28.14
  • LCNB 13.71
  • 52 Week Low
  • RCEL $6.90
  • LCNB $12.42
  • 52 Week High
  • RCEL $14.16
  • LCNB $17.92
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 56.76
  • LCNB 46.13
  • Support Level
  • RCEL $8.15
  • LCNB $13.35
  • Resistance Level
  • RCEL $9.36
  • LCNB $14.26
  • Average True Range (ATR)
  • RCEL 0.67
  • LCNB 0.68
  • MACD
  • RCEL 0.15
  • LCNB -0.01
  • Stochastic Oscillator
  • RCEL 93.90
  • LCNB 37.56

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About LCNB LCNB Corporation

LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.

Share on Social Networks: